Humana (HUM) Cost of Revenue (2009 - 2026)

Humana has reported Cost of Revenue for 18 years, with the latest figure at $33.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 27.03% year-over-year to $33.7 billion; the trailing twelve-month figure through Mar 2026 stood at $118.0 billion (up 15.59% YoY), and the FY2025 full-year result was $110.8 billion, up 10.08% from the prior year.
• Cost of Revenue for Q1 2026 stood at $33.7 billion, up from $28.7 billion in the prior quarter.
• The five-year high for Cost of Revenue was $33.7 billion in Q1 2026, with the low at $18.4 billion in Q3 2022.
• Average Cost of Revenue over 5 years is $24.1 billion, with a median of $25.0 billion recorded in 2024.
• Year-over-year, Cost of Revenue climbed 5.62% in 2025 and advanced 27.03% in 2026.
• Tracing HUM's Cost of Revenue over 5 years: stood at $18.6 billion in 2022, then gained by 22.6% to $22.8 billion in 2023, then advanced by 11.41% to $25.4 billion in 2024, then rose by 13.16% to $28.7 billion in 2025, then gained by 17.36% to $33.7 billion in 2026.
• The last three Cost of Revenue figures came in at $33.7 billion (Q1 2026), $28.7 billion (Q4 2025), and $28.0 billion (Q3 2025), per Business Quant data.

Peer Comparison